BioLineRx Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.7% | -39.7% | -33.2% |
| FY2022 | -49.1% | -49.1% | -32.7% |
| FY2023 | -458.4% | -458.4% | -94.8% |
| FY2024 | -68.5% | -68.5% | -23.7% |
| FY2025 | -11.1% | -11.1% | -5.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.7% | -39.7% | -33.2% |
| FY2022 | -49.1% | -49.1% | -32.7% |
| FY2023 | -458.4% | -458.4% | -94.8% |
| FY2024 | -68.5% | -68.5% | -23.7% |
| FY2025 | -11.1% | -11.1% | -5.0% |